CAMV
Concord Asset Management (Virginia)’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,380
| Closed | -$1.66M | – | 204 |
|
|
2025
Q1 | $1.66M | Sell |
3,380
-188
| -5% | -$92.6K | 0.37% | 70 |
|
|
2024
Q4 | $1.44M | Buy |
3,568
+741
| +26% | +$298K | 0.32% | 69 |
|
|
2024
Q3 | $1.31M | Buy |
2,827
+502
| +22% | +$233K | 0.3% | 68 |
|
|
2024
Q2 | $1.09M | Buy |
2,325
+773
| +50% | +$362K | 0.27% | 70 |
|
|
2024
Q1 | $649K | Buy |
1,552
+407
| +36% | +$170K | 0.17% | 92 |
|
|
2023
Q4 | $466K | Buy |
1,145
+484
| +73% | +$197K | 0.14% | 101 |
|
|
2023
Q3 | $230K | Buy |
+661
| New | +$230K | 0.08% | 117 |
|